BREAKING
Nio Inc (NIO) Beats Q4 EPS Estimates by a Wide Margin 9 minutes ago Ultralife Corp (ULBI) Reports a net loss for Q4 FY25 18 minutes ago Protara Therapeutics, Inc. (TARA) Reports Narrower Loss for Q4 34 minutes ago Apyx Medical Corporation (APYX) Reports a Net Loss for Q4 FY25 45 minutes ago Esperion Therapeutics, Inc (ESPR) Misses Q4 EPS Estimates 57 minutes ago Inspired Entertainment, Inc (INSE) Misses Q4 EPS Estimates 1 hour ago DNTH Stock Jumps 21.5% Despite Wider-Than-Expected Q4 Loss as Pipeline Prospects Fuel Rally 2 hours ago SuRo Capital Corp (SSSS) Reports Wider Loss Q4 EPS Estimates by 10.0% 2 hours ago Tenax Therapeutics Inc (TENX) Reports Q4 Earnings 3 hours ago Bloom Energy (BE) Surges 12% Despite Adjusted Loss of $0.30 Per Share, Weak Q1 Outlook 4 hours ago Nio Inc (NIO) Beats Q4 EPS Estimates by a Wide Margin 9 minutes ago Ultralife Corp (ULBI) Reports a net loss for Q4 FY25 18 minutes ago Protara Therapeutics, Inc. (TARA) Reports Narrower Loss for Q4 34 minutes ago Apyx Medical Corporation (APYX) Reports a Net Loss for Q4 FY25 45 minutes ago Esperion Therapeutics, Inc (ESPR) Misses Q4 EPS Estimates 57 minutes ago Inspired Entertainment, Inc (INSE) Misses Q4 EPS Estimates 1 hour ago DNTH Stock Jumps 21.5% Despite Wider-Than-Expected Q4 Loss as Pipeline Prospects Fuel Rally 2 hours ago SuRo Capital Corp (SSSS) Reports Wider Loss Q4 EPS Estimates by 10.0% 2 hours ago Tenax Therapeutics Inc (TENX) Reports Q4 Earnings 3 hours ago Bloom Energy (BE) Surges 12% Despite Adjusted Loss of $0.30 Per Share, Weak Q1 Outlook 4 hours ago
ADVERTISEMENT
Breaking News

Ultralife Corp (ULBI) Reports a net loss for Q4 FY25

Ultralife Corp (ULBI) reported Q4 2025 gaap earnings of $0.01 per share. No consensus estimate was available for comparison. Top-line revenue was $43.9M.

$ULBI March 10, 2026 1 min read
NYSE
$ULBI · Earnings

Ultralife Corp (ULBI) reported Q4 2025 gaap earnings of $0.01 per share. No consensus estimate was available for comparison. Top-line revenue was $43.9M.

Ultralife Corp (ULBI) reported a net loss of $0.45 per share for Q4 2025. No consensus estimate was available for comparison. Top-line revenue was $48.5M.

Ultralife Corporation designs, manufactures, installs, and maintains power, communication and electronics systems worldwide. The company operates through two segments: Battery & Energy Products and Communications Systems.

The Newark, New York-based firm serves customers globally with its specialized power solutions and communications technology.

This article was generated using AlphaStreet’s proprietary financial analysis technology and reviewed by our editorial team.

ADVERTISEMENT
Tags: #ULBI